Olverembatinib dimesylate

Vendor: Abmole

Type: Molecular

SKU: M2749

$126.50 USD
Shipping calculated at checkout.

Documents

Coa

Available in stock (500)

  • Customs clearance fees may apply
  • Worldwide shipping available.
For research use only — not intended for clinical or diagnostic purposes.

Product Overview

Bioactivity
Olverembatinib (GZD824) dimesylate is a third-generation oral effective BCR-ABL inhibitor, acting on BCR-ABL (WT) and BCR-ABL (T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.
Casnumber
1421783-64-3
Formula
C29H27F3N6O.2CH4O3S
Mw
724.77
Psmiles
CN1CCN(CC1)CC2=C(C=C(NC(=O)C3=CC(=C(C)C=C3)C#CC4=CC5=C([NH]N=C5)N=C4)C=C2)C(F)(F)F.C[S](O)(=O)=O.C[S](O)(=O)=O
Purity
99.30%
Solubility
DMSO 90 mg/mL; Water 40 mg/mL
Target synonyms
GZD824 dimesylate; HQP1351 dimesylate
Olverembatinib dimesylate

Olverembatinib dimesylate

$126.50 USD